Status:
COMPLETED
Rapid Detection of Staphylococcus Aureus in Burn Patients
Lead Sponsor:
American Burn Association
Collaborating Sponsors:
U.S. Army Medical Research and Development Command
Conditions:
Burns
Sepsis
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if rapid early detection of the bacteria causing sepsis in burn patients improves patient outcomes.
Detailed Description
Burn patients have lost their primary barrier to microorganism invasion and therefore are continually and chronically exposed to pathogens. Ninety-seven percent of patients with \>20% total body surfa...
Eligibility Criteria
Inclusion
- 20% or \> TBSA burns at hospital admission
- will require BC during hospital stay
- Patient/surrogate able to sign consent
Exclusion
- allergic to nafcillin, cefazolin, vancomycin, linezolid, and/or daptomycin
- on antibiotic(s) prior to first BC
Key Trial Info
Start Date :
May 30 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 29 2019
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT01140269
Start Date
May 30 2010
End Date
September 29 2019
Last Update
August 4 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Davis Medical Center-Regional Burn Center
Sacramento, California, United States, 95817
2
University of Miami Health System
Miami, Florida, United States, 33136
3
University of Cincinnati Medical Center
Cincinnati, Ohio, United States, 45221
4
Harborview Medical Center
Seattle, Washington, United States, 98104